Literature DB >> 26918680

The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey.

Jae Cooper1, Ron Borland1, Hua-Hie Yong1, Omid Fotuhi2.   

Abstract

AIMS: To determine whether abstinence or relapse on a quit attempt in the previous year is associated with current depressive symptoms.
DESIGN: Prospective cohort with approximately annual waves. Mixed-effect logistic regressions tested whether time 2 (T2) quitting status was associated with reporting symptoms at T2, and whether time 1 (T1) symptoms moderated this relationship.
SETTING: Waves 5-8 of the Four-Country International Tobacco Control Study: a quasi-experimental cohort study of smokers from Canada, the United States, the United Kingdom and Australia. PARTICIPANTS: A total of 6978 smokers who participated in telephone surveys. MEASUREMENTS: T1 and T2 depressive symptoms in the last 4 weeks were assessed with two screening items from the PRIME-MD questionnaire. Quitting status at T2: (1) no attempt since T1; (2) attempted and relapsed; and (3) attempted and abstinent at T2.
FINDINGS: Compared with no attempt, relapse was associated with reporting T2 symptoms [odds ratio (OR) = 1.46, 95% confidence interval (CI) = 1.33, 1.59]). Associations between T2 quitting status and T2 symptoms were moderated by T1 symptoms. Relapse was associated positively with T2 symptoms for those without T1 symptoms (OR = 1.71, 95% CI = 1.45, 2.03) and those with T1 symptoms (OR = 1.45, 95% CI = 1.23, 1.70). Abstinence was associated positively for those without T1 symptoms (OR = 1.37, 95% CI = 1.10, 1.71) and negatively for those with T1 symptoms (OR = 0.74, 95% CI = 0.59, 0.94). Age moderated these associations significantly. Relapse did not predict T2 symptoms for those aged 18-39 irrespective of T1 symptoms. The negative effect of abstinence on T2 symptoms for those with T1 symptoms was significant only for those aged 18-39 (OR = 0.61, 95% CI = 0.40, 0.94) and 40-55 (OR = 0.58, 95% CI = 0.40, 0.84). The positive effect of abstinence on T2 symptoms for those without T1 symptoms was significant only for those aged more than 55 (OR =1.97, 95% CI = 1.35, 2.87).
CONCLUSIONS: Most people who stop smoking appear to be at no greater risk of developing symptoms of depression than if they had continued smoking. However, people aged more than 55 who stop smoking may be at greater risk of developing symptoms of depression than if they had continued smoking.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  Abstinence; depression; relapse; smoking cessation

Mesh:

Year:  2016        PMID: 26918680      PMCID: PMC4940259          DOI: 10.1111/add.13367

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  31 in total

1.  Smoking cessation and the course of major depression: a follow-up study.

Authors:  A H Glassman; L S Covey; F Stetner; S Rivelli
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

Review 2.  The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?

Authors:  D J Balfour; D L Ridley
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

Review 3.  Cigarette-derived nicotine is not a medicine.

Authors:  Andrew C Parrott
Journal:  World J Biol Psychiatry       Date:  2003-04       Impact factor: 4.132

Review 4.  Methods of the International Tobacco Control (ITC) Four Country Survey.

Authors:  M E Thompson; G T Fong; D Hammond; C Boudreau; P Driezen; A Hyland; R Borland; K M Cummings; G B Hastings; M Siahpush; A M Mackintosh; F L Laux
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

Review 5.  The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project.

Authors:  G T Fong; K M Cummings; R Borland; G Hastings; A Hyland; G A Giovino; D Hammond; M E Thompson
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

6.  Depression and smoking across 25 years of the Normative Aging Study.

Authors:  Taru Kinnunen; Ari Haukkala; Tellervo Korhonen; Zandra N Quiles; Avron Spiro; Arthur J Garvey
Journal:  Int J Psychiatry Med       Date:  2006       Impact factor: 1.210

7.  Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder.

Authors:  Christopher W Kahler; Richard A Brown; Susan E Ramsey; Raymond Niaura; David B Abrams; Michael G Goldstein; Timothy I Mueller; Ivan W Miller
Journal:  J Abnorm Psychol       Date:  2002-11

8.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

9.  Factors influencing discussion of smoking between general practitioners and patients who smoke: a qualitative study.

Authors:  T Coleman; E Murphy; F Cheater
Journal:  Br J Gen Pract       Date:  2000-03       Impact factor: 5.386

10.  Development of major depression after treatment for smoking cessation.

Authors:  J Y Tsoh; G L Humfleet; R F Muñoz; V I Reus; D T Hartz; S M Hall
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

View more
  5 in total

1.  Predicting vaping uptake, vaping frequency and ongoing vaping among daily smokers using longitudinal data from the International Tobacco Control (ITC) Four Country Surveys.

Authors:  Gary Chan; Kylie Morphett; Coral Gartner; Janni Leung; Hua-Hie Yong; Wayne Hall; Ron Borland
Journal:  Addiction       Date:  2019-01-21       Impact factor: 6.526

2.  Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up.

Authors:  Lenka Stepankova; Eva Kralikova; Kamila Zvolska; Alexandra Pankova; Petra Ovesna; Milan Blaha; Leonie S Brose
Journal:  Ann Behav Med       Date:  2017-06

Review 3.  Effects of behavioural activation on substance use and depression: a systematic review.

Authors:  Carmela Martínez-Vispo; Úrsula Martínez; Ana López-Durán; Elena Fernández Del Río; Elisardo Becoña
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-09-29

4.  Implication of problematic substance use in poststroke depression: an hospital-based study.

Authors:  Igor Sibon; Sylvie Berthoz; Yolaine Rabat
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

5.  Smoking cessation for improving mental health.

Authors:  Gemma Mj Taylor; Nicola Lindson; Amanda Farley; Andrea Leinberger-Jabari; Katherine Sawyer; Rebecca Te Water Naudé; Annika Theodoulou; Naomi King; Chloe Burke; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.